<DOC>
	<DOC>NCT02064673</DOC>
	<brief_summary>This is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival.</brief_summary>
	<brief_title>Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy</brief_title>
	<detailed_description>This is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival in patients after radical prostatectomy compared to placebo</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>radical prostatectomy for adenocarcinoma of prostate pathologically confirmed T1T3 disease no sign of lymph node or metastatic disease Eastern Cooperative Oncology Group(ECOG) status 02 adequate renal and liver function no plan to receive adjuvant hormone or radiation therapy life expectancy of 3 years must not have exceeded 3 months from time of surgery to enrollment into study T3b or T4 or node positive disease hormone therapy before surgery history of gallbladder problems or gallstones, or biliary obstruction radiation therapy as primary treatment after surgery antiplatelet or anticoagulant agents history of gastric or duodenal ulcers or hyperacidity syndromes</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>radical prostatectomy</keyword>
</DOC>